he PRECISE Group established in 1997, with an annual turnover of 40 million USD is among the respected pharmaceutical companies in India. With a Well-trained regulatory team, dedicated F&D unit and 100+ professionals Precise Group has been established as a one-stop solution for API, Intermediates and Finished Formulations. With our core strengths, we are making our base stronger in the global market.
The Precise group started with Bulk Drug manufacturing and then diversified into Drug Pellets and Formulations to provide our customers with end-to-end solutions to their various pharmaceutical product needs. The Group is slowly making its presence felt in the competitive healthcare market with its fair business practices, consistent customer services and quality of medical products. It is poised to become a leading Pharmaceutical Manufacturer in India and Internationally. The Group now exports to almost 30 countries and it is also an approved API supplier to manufacturers like ABBOTT, SUN PHARMA, TEVA, RANBAXY, Dr. REDDY’s, PLIVA and several other key pharma players in the markets around the world. Our Core Strengths
Precise Group follows the tradition of Dedication, Professional Integrity and Robust R&D in the pursuit of excellence. With leading brands in various therapeutic segments, our products have proved to be efficient and effective in areas of Cardiovascular, CNS, Gastro-Intestinal, Diabetology, Anti-Infective, VMN and Pain Management solutions. We had developed core competencies in manufacturing drugs in various therapeutic areas.
Latest at Precise
As a research-based pharmaceutical company, we are continuously working on differentiated medicines for the future. From Injectables, biosimilars and niche technologies, the group is exploring different ideas, concepts and continuously innovating.
ntroduced for the First Time in India
Introduced PFS for the First Time in the World
Carbetocin Injection 100 mcg/ml (Vial/PFS)
Patent No. : 398606
For the prevention of uterine atony following delivery of the infant by caesarean section under epidural or spinal anaesthesia or by vaginal delivery.Trust the Best
Levocloperastine Fendizoate Oral Suspension
Effective Antitussive agent for the treatment of cough in patients of all ages. DCGI Approved
Tofacitinib Ointment 2% w/w
For the treatment of mild to moderate Atopic Dermatitis (AD) in patients of 18 years & above having flare up of disease. DCGI Approved
Amorolfine Lotion 0.25%
Launching soon a topical lotion for the effective treatment of Dermatomycoses (of Skin, Hair & Nails), Cutaneous Candidiasis . & Pityriasis Versicolor. Introduced for the First Time in India
Ozenoxacin Lotion 2%
A topical quinolone showing potent antimicrobial activities against Gram-negative and Gram-positive bacteria and is widely used for the treatment of Inflammatory Acne & Superficial Infections. Introduced for the First Time in India
Magnesium Sulphate IV Infusion 4% w/v
Simplified, 4 gm MgSO4 in 100 ml Sterile Water. Ready to Administered, Gold Standard in Pre-eclampsia & Eclampsia Treatment. Dual Action for Quick Pain Relief
Polmacoxib Capsules 2 mg
DCGI APPROVED
First-in-class NSAID with dual action inhibitor of COX-2 and Carbonic Anhydrase (CA), used to treat osteoarthritis.
